Back to search results

Groceries Plus Lifestyle Intervention for Hypertension and Type 2 Diabetes

This 6-month study, called DASH-Life, is for adults with high blood pressure (hypertension) and type 2 diabetes who live in Baltimore areas with limited access to healthy foods. It aims to see if encouraging healthy eating and providing weight management guidance can lower blood pressure and blood sugar. You would either receive telephone coaching and support (Coach-Directed Tailored DASH Groceries Plus Lifestyle Intervention) or a brochure with healthy eating advice and a gift card for groceries (Self-Shopping DASH diet advice). We're looking at how many people join and how acceptable the intervention is. To join, you need to be 18 or older, have type 2 diabetes, a specific blood pressure range, and certain kidney function (eGFR ≥45 mL/min/1.73m2) and potassium levels. The study plans to enroll 80 participants, but its current recruitment status is unclear.

Study design
This is an interventional study planning to enroll 80 participants. It compares two different approaches to lifestyle intervention.
What's involved
Participants in the Coach-Directed group will have an initial 1-hour phone meeting and then weekly 15-30 minute phone calls for three months. Participants in the Self-Shopping group will receive a brochure and a gift card for groceries for the first three months.
Compensation
Participants in the Self-Shopping DASH diet advice group will receive a gift card to shop at a local supermarket.
Follow-up
Feasibility is assessed at the start of the study, and acceptability is assessed at 3 months. The study itself is 6 months long.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06921356

Groceries Plus Multi-Component Lifestyle Intervention for Adults With Hypertension and Type 2 Diabetes

Recruiting
NAAges 18+Interventional
Johns Hopkins University
~80 participants
Updated 2026-03-24 on ClinicalTrials.gov
What's tested:Coach-Directed Tailored DASH Groceries Plus Lifestyle InterventionSelf-Shopping DASH diet advice

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Feasibility as assessed by the number of participants enrolled
Measured over Baseline
+1 more outcome measured

Conditions

Hypertension
Type 2 Diabetes Mellitus (T2DM)

Explore related trials

HypertensionType 2 Diabetes Mellitus

Where it's being run

1 sites across 1 states
Maryland1

Study leadership

  • Jessica Yeh, PhD · PRINCIPAL_INVESTIGATOR · Johns Hopkins University

Who to contact

Jessica Yeh, PhD
[email protected]
410-614-4316
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age 18 years or older
Diabetes Mellitus Type 2 defined by: self-reported type 2 diabetes diagnosis, or HbA1c\>=6.5%, or treatment of diabetes with diabetes medications(s)
Baseline systolic BP 120-159 mmHg (with or without medications.)
Serum potassium level \>3.0 and \<5 mmol/L,
Estimated glomerular filtration rate (eGFR) \>=45 mL/min/1.73m2.
Willing and able to complete required procedures in English.
Living in Healthy Food Priority Area in Baltimore; the US Department of Agriculture (USDA) defined low income, low access areas, or census blocks with area deprivation index (ADI) 60 and above (State Decile\>=6.)

Exclusion

Hypoglycemia requiring hospitalization or the assistance of another person in the last 6 months
Cardiovascular event within 6 months
On diabetes or weight loss medications such as glucagon-like peptide 1 (GLP-1), GLP-1/glucose-dependent insulin-releasing peptide (GIP), insulin, or any combination of these medications
HbA1c ≥ 10%
Type 1 diabetes
Baseline systolic BP \< 100 mmHg
Weight \>400 lbs due to the maximum weight on study scale
Chronic disease that might interfere with trial participation
Current participation in another clinical trial that might affect blood pressure, weight loss, diabetes, or ability to adhere to study procedures
Current participation in program with conflicting dietary guidance (i.e., meal replacement or keto diets)
Unwillingness or inability to adopt a DASH-like diet
Planning to leave area in the next 6 months

What this trial measures

  • Feasibility as assessed by the number of participants enrolledBaseline

    The observed count of responses to the prescreening will be summarized. Recruitment yields at screening visit and randomization visit will be derived.

  • Acceptability as assessed by the Acceptability of the Intervention Measure survey3 months

    Acceptability of the intervention will be quantitatively measured by the Acceptability of Intervention Measure (AIM) survey. The survey consists of 4 items, each measured on a 5-point Likert scale from 1 (completely disagree) to 5 (completely agree). The score is calculated as the mean of the responses to the 4 items. A higher score is better.